AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Gencell Ltd.

Regulatory Filings Sep 2, 2024

6807_rns_2024-09-02_99d15792-52f7-49b7-8164-5271503f8e19.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

Investors Presentation - August 2024 false

�'��� ��"� 1 818
GENCELL LTD
Corporation no: 514579887 13072
- - -
Israel Securities Authority Tel Aviv Stock Exchange �150 ( Public ) Reported via MAGNA: 02/09/2024
www.isa.gov.il www.tase.co.il Reference: 2024-01-600137 Time of broadcast: 10:06 10:06

Amended report for distorted report sent on date 27/08/2024 Whose reference number was: 2024-01-094327

The distortion: Amendment of slide 2 to the presentation at the request of the Securities Authority. Deleting the sentence "The Company is not responsible for the completeness or accuracy of the information, and it will not bear any liability for any damages and/or losses which may be incurred due to the use of the information." and added the sentence "The presentation includes data and assessments based on external sources, the content of which has not been independently examined by the Company and therefore the Company is not responsible for their correctness."
The distortion cause: As detailed in the 'disruption' rubric above.
The main amendment: As detailed in the 'disruption' rubric above.

English language report to Israeli corporateThis form is for reports that has been translated to English (convenience translation) and should be published alongside with the report in Hebrew in accordance with the Securities Regulations (Periodic and Immediate Reports), 5730 - 1970.

References of previous reports relating to this matter:   _________   _________   _________

The information included in this presentation (the "Information") is presented for convenience only and does not exhaust all of the data about GenCell Ltd. and it's subsidiaries (all together, the "Company") and the Company's activities, and does not substitute the review of the more detailed information contained in the Company�s Periodic Report and its immediate reports, as reported via the Magna distribution site to the Israeli Authority Securities (the "ISA") and the Tel Aviv Stock Exchange Ltd. (the "TASE") including the Company�s periodic report for the first half of 2024. This presentation does not constitute an offer to buy or sell or an invitation to accept offers to purchase any securities of the Company and is intended to the be informational only. The information does not constitute a basis for making an investment decision, nor does it constitute a recommendation or opinion or substitute for the discretion of a potential investor. This presentation includes forward-looking information, as defined in the Securities Law, 5728-1968. In any event of contradiction or discrepancy between this translation and the Hebrew version of the presentation, the Hebrew version shall prevail.

Attached hereto is a report on Investors Presentation - August 2024

H1_2024_Investors_Update_ENG_isa.pdf

Reference to parallel Hebrew report: 2024-01-094324
This report was not reported in Hebrew.

Details of the authorized signatories to sign on behalf of the corporation:

Name of the signer Corporate Role
1 Yossi Salomon CFO

_________

Note: According to Rule 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these Regulations will be signed by the authorized persons to sign on behalf of the corporation. For the ISA staff notice Click here .2 2

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: �'��� Date of revision of form structure: 06/08/2024
Address: ������ 7 , ��� ����� 4951025   , Tel: 03-7261616 , Fax: 03-7261617
E-mail address: [email protected]   Company site: www.gencellenergy.com
Previous names of reporting entity:
Name of the Signatory: ����� ���� Position of Signatory in the reporting corporation: Name of Employer Company:
Address: ������ 7 , ��� ����� 4951025 Telephone: 03-7261616 Facsimile: 03-7261617 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.